Novotech Releases In-Depth 2023 Global Clinical Trial Landscape Reports on Hemophilia and Primary Biliary Cholangitis
02 nov. 2023 03h48 HE
|
Novotech
Novotech today published the latest 2023 global clinical trial landscape reports on Primary Biliary Cholangitis (PBC) and Hemophilia.
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
01 nov. 2023 16h05 HE
|
Prelude Therapeutics, Inc.; AbCellera
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
Clinical Trials Supplies Market Worth $3.29 Billion by 2027 - Exclusive Report by The Insight Partners
26 oct. 2023 07h42 HE
|
The Insight Partners
Pune, India, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The clinical trial is an investigation study that defines whether a medical approach, therapy, or device is effective, safe, and useful for human...
Larkspur Biosciences to Present New Mechanistic Data on the Role of Pin1 in Modulating the Fibroblast – Cancer Axis at SITC 2023
25 oct. 2023 08h00 HE
|
Larkspur Biosciences, Inc.
WATERTOWN, Mass., Oct. 25, 2023 (GLOBE NEWSWIRE) -- Larkspur Biosciences, a biotechnology company building precision therapies to outsmart cancer, announced that data supporting development of a...
Preclinical CRO Market: Projected Expansion to Reach USD 10.5 Billion by 2032, Sustaining a Consistent 7.5% CAGR
19 oct. 2023 09h38 HE
|
Market.Us
New York, Oct. 19, 2023 (GLOBE NEWSWIRE) -- The Preclinical CRO Market size is expected to be worth around USD 10.5 Billion by 2032 from USD 5.2 Billion in 2022, growing at a CAGR of 7.5% during the...
Macomics Announces the Appointment of Kevin Lee as Independent Non-Executive Director
19 oct. 2023 04h00 HE
|
Macomics Limited
EDINBURGH and CAMBRIDGE, United Kingdom, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Macomics Ltd, a leader in macrophage drug discovery, announces that it has appointed Kevin Lee Ph.D., MBA as Independent...
Muscular Dystrophy Association Celebrates FDA Approval of ZILBRYSQ® zilucoplan for the Treatment of Generalized Myasthenia Gravis (gMG) in Adult Patients
18 oct. 2023 14h36 HE
|
Muscular Dystrophy Association
New York, Oct. 18, 2023 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) celebrates the US Food and Drug Administration (FDA) approval of ZILBRYSQ® zilucoplan for the treatment of...
Modifi Bio Raises Additional $4.3 Million in Seed Funding
16 oct. 2023 07h00 HE
|
Modifi Biosciences
NEW HAVEN, Conn., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Modifi Biosciences, a leader in DNA modification as a novel approach to target cancer, today announced the closing of $4.3 million in a second...
Novotech Announces Key Leadership Appointments: Rick Farris, North America Managing Director and Dr. David Ng, Global Vice President of Biometrics and Data
12 oct. 2023 23h38 HE
|
Novotech
Novotech announces significant senior executive hires to further expand services for Novotech’s global biotech clients.
Dr. Yooni Kim, Vice President of Clinical Services at Novotech, Delivers Keynote Address at Veeva Korea Summit
12 oct. 2023 05h03 HE
|
Novotech
Dr. Yooni Kim, Vice President of Clinical Services at Novotech, served as a keynote speaker at the Veeva Korea Summit this week in Seoul, Korea